Flatiron Health UK's Adam Manhi joined CuriaUK for a roundtable on data's role in cancer—sharing how we use #RWD to create a deep network for research, driving new opportunities for biopharma & returning insights to the @NHS to improve care.

Learn more: flatironhealth.co.uk

Most #MM induction treatments involve bortezomib given twice-weekly, but recent research shows once-weekly may be as effective + fewer side effects. A study publshd in Blood Cancer Journal examines how the drug is currently used & effectiveness in real-world.

flatiron.com/resources/bort…

After learning about David Fajgenbaum, MD's unique journey with Castleman disease, Flatiron engineers used ML to better leverage Flatiron data, unlocking insights for a rare patient population.

Read our #LearnTeachGrow article for a behind the scenes look:
linkedin.com/pulse/using-ma…

ANNOUNCED TODAY: Flatiron is expanding their collaboration with National Comprehensive Cancer Network (NCCN) to further enable research with #RWD , create meaningful impact on cancer care, & allow cancer centers access to data sets to evaluate & enhance the quality of care given at their sites.
flatiron.com/resources/nccn…

Head of Healthcare Quality & Safety at Flatiron Health shared with AJMC that he sees it necessary for health care vendors and providers to consider the risk & safety of AI tools as the industry awaits the roll out of more regulations.

Read more: ajmc.com/view/dr-stephe…

Our recent study, leveraging #RWD , examines the effects of broadening eligibility criteria on diversity in trials potentially increasing representation for historically underrepresented groups, providing crucial insights on inclusive trial design.

More: flatiron.com/resources/broa…

Nathan Hobrath's experience as Flatiron Associate Principal of Clinical Research Partnerships positions him as a subject matter expert for our clinical research teams, further enhancing his role as a dynamic leader in our new life sciences hub.

linkedin.com/pulse/meet-our…

From the vibrant streets of NYC to the charm of Raleigh-Durham area, Flatiron Health is making an impact in cancer care and research. Apply today: bit.ly/3ONI8pC

Meet with Flatiron experts at the Community Oncology Conference to explore how our tech empowers practices to thrive amidst the challenges of community practice.

Schedule time with the team:

events.flatiron.com/amccbs-coa-202…

Flatiron Health & Smirta Innovations to partner to bring smart scheduling tool, OncoSmart®, to practices using OncoEMR®, reducing burdens on HCPs, saving time, & driving the best quality care for people with cancer.

Learn more from our point of care team @ #COA24
flatiron.com/resources/flat…

Hear from Flatiron's VP of Strategic Partnerships & Alliances Nina Chavez on the exciting things happening at the Community Oncology #COA24 next week!

Our experts will be onsite excited to discuss the latest trends in care and tech, to schedule time visit: events.flatiron.com/amccbs-coa-2024

#NewResearch published today in NEJM Evidence, investigates how #RWD use to optimize and broaden inclusion criteria impacts the diversity of eligible patients with cancer.

Hear from Maneet Kaur about the study's inspiration and explore the full pub: flatiron.com/resources/broa…

We’re stronger together — it’s the power of collaboration. Join Flatiron Health at Community Oncology's '24 Conference.

Visit us at booth #213 and meet with our experts to discover the latest advancements in OncoEMR, Flatiron Assist, and Flatiron Clinical Pipe. events.flatiron.com/amccbs-coa-202…

There are disparities in NGS testing rates, particularly among Black/Latinx patients.
Researchers from West Cancer Center & Research Institute, OneOncology, TennesseeOncology, NYCancerSpecialists, Genentech , Foundation Medicine, & Flatiron collaborated to provide adtl insight — learn more: flatiron.com/resources/raci…

At Flatiron Health, we’re tackling #HTA challenges head-on with insights from Head of Outcomes Research & Evidence Generation, Intl, Dr. Blythe Adamson.

Explore our latest research on the concept of transportability for informed healthcare decision-making:
flatiron.com/resources/tran…

ML, NLP, & AI each have distinct potential within healthcare.

Will Shapiro, Flatiron’s VP of Data Science, shared his thoughts on the potential for AI tools in oncology & the importance of understanding the terminology & concepts behind each.

Read more: pharmacytimes.com/view/unlocking…

Collecting & reporting trial data has many notorious challenges that can be solved through innovative technology described in this e-book, published with AppliedClinicalTrial Magazine

Read for methods & products available to help sites navigate these challenges—
appliedclinicaltrialsonline.com/view/ehr-to-ed…

Flatiron Health & American Cancer Society's Real-World Data Impact Award offers a unique opportunity to drive research answering key questions for patients w/ cancer

⏯️Watch now for a live roundtable with this year’s grantees, moderated by Aaron Cohen, MD page.flatiron.com/2023-real-worl…

Senior Data Insights Engineer Megan Hildner’s work in #machinelearning is enabling the Data Insights team to scale real-world data extraction at Flatiron Health.

Read our recent #MeetOurChangemakers interview for more: linkedin.com/pulse/meet-our…